TrialCancer biology & therapy2015

A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer.

S Cowherd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.